Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Cyclophosphamide, Paclitaxel, and Trastuzumab in Stage I-II HER2+ Breast Cancer
NCT02654119Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Dec 2015
- Primary completion
- Dec 2025
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, Paclitaxel Micelles for Injection, trastuzumab in breast cancer, sponsored by University of Nebraska. Started Dec 2015; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02654119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654119.